bullish
GoodRx IPO: A Healthy Prescription for Strong Topline Growth and Profits
344 Views21 Sep 2020 13:38
GoodRx (GDRX) offers a prescription aggregation platform in the US enabling healthcare professionals to provide prices from the platform directly...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 10-minute read)
Discussions
(Paid Plans Only)
- oRo: Another Stock Capable of Making PM Suga’s Digitalisation Dream a Real07 Oct 2020
- Freee KK: Quantamental Reveals the Company May Break-Even Over the Next 2-Years02 Oct 2020
- M3 Inc: Intelligent Adaption to Covid-19 Should Sustain Medtech Earnings Growth Even Post-Pandemic24 Sep 2020
- GoodRx IPO: A Healthy Prescription for Strong Topline Growth and Profits21 Sep 2020
- ZTO Express Secondary: Overvalued and More Expensive than Global Delivery Giants18 Sep 2020
- Genor Biopharma IPO: Strong Clinical Pipeline with Some Potential Blockbusters17 Sep 2020
- Boqii IPO: Another Pet Humanization Stock in a Booming Market Led by Large E-Commerce Platforms10 Sep 2020
x